Adverse side effects associated with latanoprost

被引:75
作者
Rowe, JA
Hattenhauer, MG
Herman, DC
机构
[1] Mayo Clinic, Rochester, MN 55905
关键词
D O I
10.1016/S0002-9394(14)70907-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To report three different adverse reactions after initiating treatment with latanoprost. METHOD: Serial clinical examinations of three patients were performed. RESULTS: Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starring topical latanoprost for the treatment of primary open-angle glaucoma. CONCLUSION: Clinicians should be alerted to these possible complications of topical latanoprost therapy.
引用
收藏
页码:683 / 685
页数:3
相关论文
共 2 条
[1]   A six-month, randomized, double masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension [J].
Watson, P ;
Stjernschantz, J ;
Beck, L ;
Blackmore, M ;
Coakes, R ;
Reynolds, P ;
Davey, C ;
HickmanCasey, J ;
Elkington, A ;
Luff, A ;
Green, F ;
Valenzuela, F ;
Longstaff, S ;
Currie, Z ;
Mills, B ;
Chatterjee, A ;
Murray, S ;
Nagasubramanian, S ;
Potts, M ;
Spencer, I ;
Roxburgh, S ;
Sanders, R ;
Bailey, M ;
Vernon, S ;
Sloper, M ;
Wishart, P ;
Birch, M .
OPHTHALMOLOGY, 1996, 103 (01) :126-137
[2]   THE EFFECTS ON AQUEOUS DYNAMICS OF PHXA41, A NEW PROSTAGLANDIN-F2-ALPHA ANALOG, AFTER TOPICAL APPLICATION IN NORMAL AND OCULAR HYPERTENSIVE HUMAN EYES [J].
ZIAI, N ;
DOLAN, JW ;
KACERE, RD ;
BRUBAKER, RF .
ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (10) :1351-1358